华大智造：关于变更持续督导保荐代表人的公告

Core Viewpoint - BGI Genomics announced a change in its sponsor representative for the ongoing supervision of its 2022 A-share IPO project, ensuring continuity in oversight responsibilities [1] Group 1 - CITIC Securities was appointed as the sponsor for BGI Genomics' 2022 A-share IPO project, with the supervision period lasting until December 31, 2025 [1] - The original sponsor representatives, Mr. Xiao Shaochun and Mr. Lu Ming, were responsible for the continuous supervision duties [1] - Mr. Xiao Shaochun will no longer be responsible for the supervision due to a work adjustment, and Mr. Wang Helin has been appointed to take over his responsibilities [1]